Conducting a COVID-19 drug and vaccine clinical trial

Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-06-30

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data